CardioMech Expands Mitral Leadership Team

CathWorks FFRangio™ System Receives National Reimbursement Approval in Japan

CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the application to provide reimbursement for the CathWorks FFRangio™ System,...

Levine Leichtman Capital Partners Sells FlexXray

Levine Leichtman Capital Partners ("LLCP"), a Los Angeles-based private equity firm, announced today that it has sold its portfolio company FlexXray Holdings, LLC ("FlexXray" or...

March 18, 2019

CardioMech AS, today announced it has expanded its leadership team with the election of two new board directors: Kathleen Tune of Fourth Element Capital, and Frederik Groenewegen of 415 CAPITAL, a board advisor, Vic Bertrand, and appointed Daniele Salamone as Vice President of Finance.

The CardioMech device is a highly differentiated technology designed to significantly improve the standard of care for patients suffering from severe, symptomatic degenerative mitral regurgitation due to prolapse or flail. “I am extremely pleased to announce this expansion of CardioMech’s mitral leadership team with the addition of four experienced medical technology professionals,” said Rick Nehm, President and CEO of CardioMech.

Kathleen is a proven healthcare executive with over 25 years of investing and business experience. She co-founded and manages a healthcare investment firm Fourth Element Capitaland previously was a partner at the healthcare investment firm Thomas, McNerney & Partners.“CardioMech is participating in one of the most innovative segments of medicine with a significant unmet need,” said KathleenTune.Frederik, co-founder and managing director of 415 CAPITAL, a designated medical technology investment firm whose senior team has backed over 45 novel medical device technologies, including CoreValve (Medtronic), CardiAQ (Edwards Lifesciences), and Claret (Boston Scientific).

Frederik brings extensive fundraising, M&A, and commercialization experience to the company’s team. “Transcatheter mitral valve repair is a hot market segment, and we believe the company is strongly positioned for a leadership role in chordal repair,” said FrederikGroenewegen.

Vic, a veteran medical technology investor, and director who was appointed as a company advisor is also an entrepreneur with30 years’ experience in medical technology, manufacturing, and real estate, said, “I am thrilled to support Rick and the CardioMech team on their mission to bring this innovative and much-needed solution to the affected population globally,” said Vic Bertrand.

Daniele Salamone, CardioMech’snew Vice President of Finance, brings tremendous experience to the company to accelerate and guide the creation of shareholder value. He is an experienced strategy consultant with expertise in corporate development, strategic planning, and M&A transactions. His background is in innovation with startups and corporate innovation initiatives. He has direct experience with structural heart device commercialization. He was most recently atThe Boston Consulting Group



Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.